Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 19, 2019Journal of Clinical OncologyOpen Access

Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study

View Full Paper
Ask AI
Bookmark
Share

Authors

JWJoan L. WalkerMBMark F. BradyLWLari Wenzel

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Walker et al. (2019) studied this question.

synapsesocial.com/papers/6a0cc2bda4d785ea81625485https://doi.org/10.1200/jco.18.01568
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Combining Distribution- and Anchor-Based Approaches to Determine Minimally Important Differences2005 · 385 citations
  2. 2Use of CA-125 to Define Progression of Ovarian Cancer in Patients With Persistently Elevated Levels2001 · 205 citations
  3. 3Ovarian cancer statistics, 20182018 · 3,754 citations
  4. 4Reliability and Validity of the Functional Assessment of Cancer Therapy–Ovarian2001 · 284 citations
  5. 5Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial1975 · 2,392 citations